These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck). Sabat M; Vanrens JC; Brugel TA; Maier J; Laufersweiler MJ; Golebiowski A; De B; Easwaran V; Hsieh LC; Rosegen J; Berberich S; Suchanek E; Janusz MJ Bioorg Med Chem Lett; 2006 Aug; 16(16):4257-61. PubMed ID: 16757169 [TBL] [Abstract][Full Text] [Related]
28. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors. Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688 [TBL] [Abstract][Full Text] [Related]
29. 4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonists. Trabanco AA; Pullan S; Alonso JM; Alvarez RM; Andrés JI; Boeckx I; Fernández J; Gómez A; Iturrino L; Janssens FE; Leenaerts JE; De Lucas AI; Matesanz E; Meert T; Steckler T Bioorg Med Chem Lett; 2006 Jan; 16(1):146-9. PubMed ID: 16236510 [TBL] [Abstract][Full Text] [Related]
30. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines. Boukli L; Touaibia M; Meddad-Belhabich N; Djimdé A; Park CH; Kim JJ; Yoon JH; Lamouri A; Heymans F Bioorg Med Chem; 2008 Feb; 16(3):1242-53. PubMed ID: 17993277 [TBL] [Abstract][Full Text] [Related]
31. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one. Coutrot P; Claudel S; Didierjean C; Grison C Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473 [TBL] [Abstract][Full Text] [Related]
32. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of spiro[chroman-2,4'-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors. Shinde P; Srivastava SK; Odedara R; Tuli D; Munshi S; Patel J; Zambad SP; Sonawane R; Gupta RC; Chauthaiwale V; Dutt C Bioorg Med Chem Lett; 2009 Feb; 19(3):949-53. PubMed ID: 19097787 [TBL] [Abstract][Full Text] [Related]
34. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones. Kurogi Y; Inoue Y; Tsutsumi K; Nakamura S; Nagao K; Yoshitsugu H; Tsuda Y J Med Chem; 1996 Mar; 39(7):1433-7. PubMed ID: 8691473 [TBL] [Abstract][Full Text] [Related]
36. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines. Chen A; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Grimm E; Han Y; Houle R; Huang JQ; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; McKay D; Percival MD; Regan C; Regan H; St-Jacques R; Toulmond S Bioorg Med Chem Lett; 2011 Jul; 21(13):3970-5. PubMed ID: 21621998 [TBL] [Abstract][Full Text] [Related]
37. Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis. Guo T; Shao Y; Qian G; Rokosz LL; Stauffer TM; Hunter RC; Babu SD; Gu H; Hobbs DW Bioorg Med Chem Lett; 2005 Aug; 15(16):3696-700. PubMed ID: 15978811 [TBL] [Abstract][Full Text] [Related]
38. N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors. Xu YJ; Miao HQ; Pan W; Navarro EC; Tonra JR; Mitelman S; Camara MM; Deevi DS; Kiselyov AS; Kussie P; Wong WC; Liu H Bioorg Med Chem Lett; 2006 Jan; 16(2):404-8. PubMed ID: 16246551 [TBL] [Abstract][Full Text] [Related]
39. Discovery of a series of aminopiperidines as novel iNOS inhibitors. Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors. Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]